Oramed Pharmaceuticals's chart data is dated 2026-10-08. There is no active technical signal. There are 6 published signal records.
Oramed Pharmaceuticals last closed at $4.20 (-3.89%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is 1.0×. Its overall grade ranks 58 of 738 stocks in Healthcare.
About this company
Oramed Pharmaceuticals last closed at $4.20 (-3.89%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 58/738
Valuation grade A+
Related stocks
- Novo NordiskCompetitor
경구용 당뇨·비만 치료제 개발에서 경쟁하는 글로벌 대형 제약사
- Eli LillyCompetitor
당뇨·비만 치료제 시장의 핵심 경쟁사
- PfizerCompetitor
경구 단백질/펩타이드 및 당뇨 치료제 개발 측면에서 비교되는 대형 제약사
About Oramed Pharmaceuticals
- What technical signals does Oramed Pharmaceuticals (ORMP) have?
- Oramed Pharmaceuticals current technical signals: no active technical signal.
- Is Oramed Pharmaceuticals a cup-and-handle pattern?
- No. Oramed Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Oramed Pharmaceuticals?
- Market cap: $179.28M. Trailing 12 months PER: 1.0×. Latest quarter PBR: 0.56×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Oramed Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.